Please wait
0000059478ELI LILLY & CoS-3ASREX-FILING FEES00000 0000059478 2025-01-31 2025-01-31 0000059478 1 2025-01-31 2025-01-31 0000059478 2 2025-01-31 2025-01-31 0000059478 3 2025-01-31 2025-01-31 0000059478 4 2025-01-31 2025-01-31 0000059478 5 2025-01-31 2025-01-31 0000059478 6 2025-01-31 2025-01-31 0000059478 7 2025-01-31 2025-01-31 iso4217:USD
Exhibit 107
Calculation of Filing Fee Tables
Form
S-3
(Form Type)
Eli Lilly and Company
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
 
                         
     Security
Type		  
Security
Class
Title
  
Fee
Calculation
or Carry
Forward
Rule
   Amount
 Registered 		   Proposed
 Maximum 
Offering
Price Per
Unit		   Maximum
 Aggregate 
Offering
Price		   Fee
Rate		   Amount of
 Registration 
Fee		   Carry
 Forward 
Form
Type		   Carry
 Forward 
File
Number		    Carry 
Forward
Initial
Effective
Date		  
 Filing Fee 
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
                         
Fees to Be
Paid
    Equity     Common Stock(1)   
 Rule 456(b) and 
 Rule 457(r) (2) 
   (3)(4)   (3)(4)    (3)(4)(5)    (2)   (2)          
    Equity   Preferred Stock(1)  
 Rule 456(b) and 
Rule 457(r) (2)
   (3)(4)   (3)(4)    (3)(4)(5)    (2)   (2)                
    Equity   Depositary Shares representing Preferred Stock(1)  
 Rule 456(b) and 
Rule 457(r) (2)
   (3)(4)   (3)(4)    (3)(4)(5)    (2)   (2)                
    Debt   Debt Securities(1)  
 Rule 456(b) and 
Rule 457(r) (2)
   (3)(4)   (3)(4)    (3)(4)(5)    (2)   (2)                
    Other   Warrants(1)  
 Rule 456(b) and 
Rule 457(r) (2)
   (3)(4)   (3)(4)    (3)(4)(5)    (2)   (2)                
    Other   Stock Purchase Contracts(1)  
 Rule 456(b) and 
Rule 457(r) (2)
   (3)(4)   (3)(4)    (3)(4)(5)    (2)   (2)                
    Other   Stock Purchase Units(1)  
 Rule 456(b) and 
Rule 457(r) (2)
   (3)(4)   (3)(4)    (3)(4)(5)    (2)   (2)                
                         
Fees
Previously
Paid
   N/A   N/A   N/A   N/A   N/A   N/A     N/A          
 
Carry Forward Securities
                         
Carry
Forward
Securities
   N/A   N/A   N/A   N/A     N/A       N/A   N/A   N/A   N/A
                   
    Total Offering Amounts     
N/A
    
N/A
 		            
                   
    Total Fees Previously Paid         
N/A
 		            
                   
    Total Fee Offsets         
N/A
 		            
                   
    Net Fee Due             
N/A
 		                    
  (1)
Separate consideration may or may not be received for securities that are issuable on exercise, conversion, settlement or exchange of other securities.
  (2)
In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, Eli Lilly and Company (the “Registrant”) is deferring payment of all of the registration fee. Registration fees will be paid subsequently on a “pay as you go” basis. The Registrant will calculate the registration fee applicable to an offer of securities pursuant to this Registration Statement based on the fee payment rate in effect on the date of such fee payment.
 
  (3)
An indeterminate aggregate initial offering price and number or amount of the securities of each identified class is being registered as may from time to time be issued at indeterminate prices, including securities that may be issued upon exercise, conversion, settlement or exchange of, any securities offered hereunder.
 
  (4)
Not specified as to each class of securities to be registered, pursuant to General Instruction II.E. of Form
S-3.
 
  (5)
Exclusive of accrued interest and accumulated dividends, if any.